Document Detail


Protection of cerebral microvasculature after moderate hypothermia following experimental focal cerebral ischemia in mice.
MedLine Citation:
PMID:  18586014     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Clinical studies have shown that the treatment of ischemic stroke with hypothermia is promising. In this animal study, we investigated the fate of the microvasculature following focal cerebral ischemia in mice with and without hypothermia. Focal cerebral ischemia was induced by occlusion of the middle cerebral artery (MCAO) (3 h) with an intraluminal filament technique. Eight mice received normothermia (36.5 degrees C, NT) and eight received hypothermia (32-34 degrees C, HT) treatment during 24 h of reperfusion. Another six mice represented the sham group. Analysis of the hypothermic group in comparison to the normothermic group revealed a significantly reduced infarct volume (NT: 63.56+/-4.62 mm3 SEM, HT: 38.09+/-4.83 mm3 SEM; P<0.01) and showed considerably ameliorated neurological deficits (Garcia-score) after 24 h (P<0.01). In addition, the degradation of the microvascular basal lamina antigen collagen type IV after normothermia was strongly reduced (P<0.05) compared to sham. Hypothermia diminished this effect so that collagen type IV was not significantly reduced compared to sham. Moreover the hemoglobin extravasation was strongly reduced under hypothermic treatment compared to the normothermic group (P<0.01). In the hypothermia group the urokinase plasminogen-activator (uPA) activity (P=0.01) was significantly decreased compared to the normothermia group. Also MMP-9 was significantly reduced (P<0.05) during hypothermic treatment. In conclusion, for the first time we show in mice that hypothermia preserves the microvascular wall structures after ischemia. We have demonstrated that hypothermia protects the basal lamina, reduces the infarct volume and hemorrhage, and reduces proteolytic enzymes. These protective effects in an additional animal model of ischemia and reperfusion strongly recommend hypothermia as a potential beneficial treatment for stroke.
Authors:
Jan Burk; Dorothe Burggraf; Milan Vosko; Martin Dichgans; Gerhard F Hamann
Related Documents :
15220774 - Combination of isoflurane and caspase inhibition reduces cerebral injury in rats subjec...
8293284 - The case of aphasia or neglect after striatocapsular infarction.
14707304 - Bedside assessment of cerebral perfusion reductions in patients with acute ischaemic st...
10677604 - The effects of n-methyl-n-nitrosourea and azoxymethane on focal cerebral infarction and...
10519514 - Anticoagulation monitoring during cardiac surgery: a review of current and emerging tec...
21148594 - Proteomic analysis of myocardial tissue from the border zone during early stage post-in...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-06-16
Journal Detail:
Title:  Brain research     Volume:  1226     ISSN:  0006-8993     ISO Abbreviation:  Brain Res.     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-15     Completed Date:  2009-01-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0045503     Medline TA:  Brain Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  248-55     Citation Subset:  IM    
Affiliation:
Department of Neurology, Ludwig-Maximilians University, Klinikum Grosshadern, Marchioninistr. 15, 81377 Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Brain Infarction / etiology,  prevention & control*
Cerebrovascular Circulation / physiology*
Collagen Type IV / metabolism
Disease Models, Animal
Hypothermia, Induced / methods*
Infarction, Middle Cerebral Artery / complications,  therapy*
Male
Matrix Metalloproteinase 2 / metabolism
Matrix Metalloproteinase 9 / metabolism
Mice
Mice, Inbred C57BL
Neurologic Examination
Reperfusion
Statistics, Nonparametric
Time Factors
Tissue Plasminogen Activator / metabolism
Urokinase-Type Plasminogen Activator / metabolism
Chemical
Reg. No./Substance:
0/Collagen Type IV; EC 3.4.21.68/Tissue Plasminogen Activator; EC 3.4.21.73/Urokinase-Type Plasminogen Activator; EC 3.4.24.24/Matrix Metalloproteinase 2; EC 3.4.24.35/Matrix Metalloproteinase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Microinjection of muscimol into the dorsomedial hypothalamus suppresses MDMA-evoked sympathetic and ...
Next Document:  Anticonvulsant impact of lesions in the ventrolateral forebrain of rats challenged with soman.